Pyxis Oncology, Inc. (PYXS)

NASDAQ: PYXS · IEX Real-Time Price · USD
1.51
-0.04 (-2.58%)
At close: Nov 28, 2023, 4:00 PM
1.48
-0.03 (-1.99%)
After-hours: Nov 28, 2023, 5:10 PM EST

Income Statement (Annual)

Millions USD. Fiscal year is Jan - Dec.
Year 2022202120202019
Selling, General & Admin
37.3518.663.851.66
Research & Development
86.1351.059.051.22
Operating Expenses
123.4869.7212.892.88
Operating Income
-123.48-69.72-12.89-2.88
Other Expense / Income
-2.766.26-0.07-0.11
Pretax Income
-120.72-75.98-12.83-2.77
Net Income
-120.72-75.98-12.83-2.77
Shares Outstanding (Basic)
33814
Shares Outstanding (Diluted)
33814
Shares Change
288.93%724.14%-75.88%-
EPS (Basic)
-3.65-8.95-12.45-0.65
EPS (Diluted)
-3.65-8.95-12.45-0.65
Free Cash Flow
-95.73-35.87-11.57-2.24
Free Cash Flow Per Share
-2.90-4.22-11.22-0.52
EBITDA
-118.88-74.72-11.99-2.77
Depreciation & Amortization
1.841.250.830
EBIT
-120.72-75.98-12.83-2.77
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).